These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 232298)

  • 1. Drug-inactivating enzymes of bacteria grown in subminimal inhibitory concentrations of antibiotics.
    Grassi GG
    Rev Infect Dis; 1979; 1(5):852-7. PubMed ID: 232298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1986 Feb; 29(2):216-24. PubMed ID: 2424366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.
    Houang ET; Greenwood D
    J Clin Pathol; 1977 Aug; 30(8):738-44. PubMed ID: 413843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-N enzymatic acetylation of gentamicin, tobramycin, and kanamycin by Escherichia coli carrying an R factor.
    Le Goffic F; Martel A; Witchitz J
    Antimicrob Agents Chemother; 1974 Dec; 6(6):680-4. PubMed ID: 4615629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and Expression of Novel Aminoglycoside Phosphotransferase Genes from Campylobacter and Their Role in the Resistance to Six Aminoglycosides.
    Zhao S; Mukherjee S; Li C; Jones SB; Young S; McDermott PF
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery period and the exposure of bacteria to subminimal inhibitory concentrations of antibiotics.
    Kitzis MD; Bouanchaud DH; Acar JF
    Rev Infect Dis; 1979; 1(5):825-31. PubMed ID: 396636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
    Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
    Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.
    Eliopoulos GM; Wennersten C; Zighelboim-Daum S; Reiszner E; Goldmann D; Moellering RC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1528-32. PubMed ID: 2847632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
    Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferable resistance and aminoglycoside-modifying enzymes in enterococci.
    Chen HY; Williams JD
    J Med Microbiol; 1985 Oct; 20(2):187-96. PubMed ID: 2995676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci.
    Ounissi H; Derlot E; Carlier C; Courvalin P
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2164-8. PubMed ID: 1963528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):598-604. PubMed ID: 393165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
    Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
    Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.
    Bongaerts GP; Kaptijn GM
    Antimicrob Agents Chemother; 1981 Sep; 20(3):344-50. PubMed ID: 6272630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Range of antibacterial activity of antibiotics at subminimal inhibitory concentrations: the ratio of minimal inhibitory concentration to minimal antibiotic concentration.
    Ezrow L; Saceanu C; Dabydeen H
    Rev Infect Dis; 1979; 1(5):821-4. PubMed ID: 396635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.